Imagine an agentic AI solution that plans and executes multi-step tasks like triaging referrals, drafting notes, flagging deteriorating patients, and surfacing care recommendations. After the flawless demo, the committee approves …
Health
-
-
Iambic Therapeutics, one of a growing number of biotech companies making artificial intelligence the center of its drug research strategy, raised $150 million in an IPO that will finance clinical …
-
Rosarium Health, a company enabling aging at home, announced Thursday that it is partnering with Anthem Medi-Cal to support home modifications for members. Through the new partnership with Anthem, Rosarium …
-
Healthcare is approaching an inflection point. The United States is projected to face a physician shortage of up to 86,000 doctors by 2036, including as many as 40,000 primary care …
-
In a MedCity News webinar for Pharmacy Week 2026, pharmacy experts will explain why stewardship should be part of the conversation about hospital cost containment and long-term sustainability. Among the …
-
Ultragenyx Pharmaceutical recently received two separate FDA approvals for gene therapies in the span of a month, each regulatory nod accompanied by a voucher the company could use to speed …
-
HealthTap, a virtual primary care company, launched a new program on Monday to support sleep and respiratory durable medical equipment (DME) suppliers. Sunnyvale, California-based HealthTap provides primary care across all …
-
Health
Healthleap Raises $38M to Expand AI Screening for Overlooked Conditions in Hospitalized Patients
Health systems are under pressure to improve patient outcomes while managing staffing shortages and rising costs. Healthleap, a clinical AI platform which works within the EHR to screen hospitalized patients …
-
A venture fund’s objective is to invest capital into early-stage companies to fuel growth, increasing the probability that they are acquired or reach public markets. That’s how an “exit” is …
-
For Roche to catch up to Eli Lilly and Novo in metabolic medicines, it needs its drugs to offer differentiation from those rivals. Roche might have just found a way, …